**Author details**

Jie Li\* and Mengxi Liu Laura and Isaac Perlmutter Cancer Center, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, USA

\*Address all correspondence to: jie.li@nyumc.org

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**147**

*The Carcinogenicity of Aflatoxin B1*

**References**

1989;**10**(3):272-283

2017;**33**(1):65-73

2003;**16**(3):497-516

[2] Ostry V, Malir F, Toman J, Grosse Y. Mycotoxins as human carcinogens—The IARC monographs classification. Mycotoxin Research.

[3] Bennett JW, Klich M. Mycotoxins. Clinical Microbiology Reviews.

[4] Kumar P, Mahato DK, Kamle M, Mohanta TK, Kang SG. Aflatoxins: A global concern for food safety, human health and their management. Frontiers

[5] Gross-Steinmeyer K, Eaton DL. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1). Toxicology. 2012;**299**(2-3):69-79

biodegradation of aflatoxin B1 using the *Bacillus licheniformis* (BL010) strain. Toxins (Basel). 2018;**10**(12):497

[7] Rushing BR, Selim MI. Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods. Food and Chemical Toxicology.

[8] Harrison JC, Carvajal M, Garner RC. Does aflatoxin exposure in the United Kingdom constitute a cancer risk? Environmental Health Perspectives.

[9] Turner PC, Flannery B, Isitt C, Ali M, Pestka J. The role of biomarkers in evaluating human health concerns

from fungal contaminants in food. Nutrition Research Reviews.

in Microbiology. 2016;**7**:2170

[6] Wang Y et al. Effective

2019;**124**:81-100

1993;**99**:99-105

2012;**25**(1):162-179

*DOI: http://dx.doi.org/10.5772/intechopen.88353*

[1] Stoloff L. Aflatoxin is not a probably human carcinogen: The published evidence is sufficient. Regulatory Toxicology and Pharmacology.

[10] Ferlay J et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer.

2015;**136**(5):E359-E386

2010;**118**(6):818-824

[13] Asim M, Sarma MP,

2011;**44**(14-15):1235-1240

1997;**18**(6):1189-1194

2013;**22**(3):305-310

683-689

[11] Mughal MJ, Xi P, Yi Z, Jing F. Aflatoxin B1 invokes apoptosis via death receptor pathway in hepatocytes. Oncotarget. 2017;**8**(5):8239-8249

[12] Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environmental Health Perspectives.

Thayumanavan L, Kar P. Role of aflatoxin B1 as a risk for primary liver cancer in North Indian population. Clinical Biochemistry.

[14] Yu MW, Chiang YC, Lien JP, Chen CJ. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males. Carcinogenesis.

[15] Hamid AS, Tesfamariam IG,

Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncology Letters. 2013;**5**(4):1087-1092

[16] Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. Journal of Gastrointestinal and Liver Diseases.

[17] Dai Y, Huang K, Zhang B, Zhu L, Xu W. Aflatoxin B1-induced epigenetic alterations: An overview. Food and Chemical Toxicology. 2017;**109**(Pt 1):

[18] Kumagai S. Intestinal absorption and excretion of aflatoxin in rats.

*The Carcinogenicity of Aflatoxin B1 DOI: http://dx.doi.org/10.5772/intechopen.88353*
